[Occurrence of cultures with episomal resistance to antibiotics among shigellae isolated in Kiev].
D000667:Ampicillin / Q000494:pharmacology; D002701:Chloramphenicol / Q000494:pharmacology; D007464:Clioquinol / Q000494:pharmacology; D015643:Erythromycin Ethylsuccinate / Q000494:pharmacology; D004926:Escherichia coli / Q000502:physiology; D005664:Furazolidone / Q000494:pharmacology; D006801:Humans; D007612:Kanamycin / Q000494:pharmacology; D009268:Nalidixic Acid / Q000494:pharmacology; D009355:Neomycin / Q000494:pharmacology; D009574:Nitro Compounds / Q000494:pharmacology; D009581:Nitrofurans / Q000494:pharmacology; D009583:Nitrofurazone / Q000494:pharmacology; D015125:Oxyquinoline / Q000031:analogs & derivatives; D010403:Penicillin Resistance; D010957:Plasmids; D011113:Polymyxins / Q000494:pharmacology; D011995:Recombination, Genetic; D012293:Rifampin / Q000494:pharmacology; D012763:Shigella flexneri / Q000187:drug effects* / Q000502:physiology; D012764:Shigella sonnei / Q000187:drug effects* / Q000502:physiology; D013307:Streptomycin / Q000494:pharmacology; D013752:Tetracycline / Q000494:pharmacology; D014455:Ukraine
D009574:Nitro Compounds; D009581:Nitrofurans; D011113:Polymyxins; D015643:Erythromycin Ethylsuccinate; D009268:Nalidixic Acid; D007612:Kanamycin; D005664:Furazolidone; D015125:Oxyquinoline; D002701:Chloramphenicol; D007464:Clioquinol; D000667:Ampicillin; D013752:Tetracycline; D009355:Neomycin; D012293:Rifampin; D009583:Nitrofurazone; D013307:Streptomycin
Rasprostranenie kul'tur s episomnoĭ ustoĭchivost'iu k antibiotikam sredi shigell, vydelennykh v Kieve